recordring97
About
Decitabine-Mediated Epigenetic Reprograming Increases Anti-leukemia Efficiency regarding CD123-Targeted Chimeric Antigen Receptor T-Cells.
Decitabine-Mediated Epigenetic Reprograming Increases Anti-leukemia Efficiency regarding CD123-Targeted Chimeric Antigen Receptor T-Cells.